A study published in The American Journal of Clinical Nutrition compared the effects of orlistat and an experimental high-protein/lower-carbohydrate diet with a control diet in Asian patients with obesity and Metabolic-associated fatty liver disease (MAFLD). Results showed that all three groups demonstrated improvement in liver steatosis at week 24. The orlistat group and the experimental diet group had significantly greater reductions in liver fat content (LFC) compared to the control group. The relative reduction in LFC was 30.2% in the experimental diet group, which was significantly higher than the 12.2% observed in the control group. Authors suggest that these interventions could be useful in the management of MAFLD, particularly in populations where compliance with lifestyle interventions may be challenging. However, further research is needed to determine the long-term efficacy and safety of these interventions.
Treatment of Obesity and Metabolic-Associated Fatty Liver Disease with a Diet or Orlistat
A recent study published in The American Journal of Clinical Nutrition found that both orlistat and an experimental high-protein/lower-carbohydrate diet were effective in reducing liver steatosis in Asian patients with obesity and Metabolic-associated fatty liver disease (MAFLD). Results showed that the orlistat group and the experimental diet group had significantly greater reductions in liver fat content (LFC) compared to the control group.
Latest from Blog
Doctors in the Upstate are conducting clinical trials on a cancer immunology vaccine that has the
A tiny fragment from the most dangerous asteroid in the solar system has arrived in the
Scientists have discovered a planet that is way too big for its tiny star. Its existence
No. 4 Florida State is aiming to win their 16th conference championship, taking on No. 14
Prince Harry and Meghan have been left off the guest list for the high society wedding
